Next generation particle accelerator diagnostics The QUASAR Group has pioneered innovative beam diagnostics solutions for accelerators and light sources. JetDose project set to optimise proton beam cancer therapy The novel beam monitor will enable non-invasive in-vivo beam dosimetry in hadron beam cancer therapy. Optical-fibre based machine protection system for particle accelerators The QUASAR Group built upon existing research outcomes to develop and commercialise a new beam loss monitoring device. Optimisation of cold-cathode flat panel X-ray source technology The QUASAR Group in collaboration with Adaptix, built upon existing research to develop and commercialise a novel chest 3D DT system.